www.euroimmun.us Open in urlscan Pro
217.7.60.1  Public Scan

Submitted URL: http://marketing.us.euroimmun.info/
Effective URL: https://www.euroimmun.us/
Submission Tags: falconsandbox
Submission: On March 16 via api from US — Scanned from US

Form analysis 1 forms found in the DOM

GET https://www.euroimmun.us

<form role="search" method="get" id="searchform" action="https://www.euroimmun.us">
  <div>
    <input class="searchfield" type="text" value="Enter Item or Catalog Number" onfocus="if (this.value == 'Enter Item or Catalog Number') {this.value = '';}" onblur="if (this.value == '') {this.value = 'Enter Item or Catalog Number';}" name="s"
      id="s">
    <input class="searchbutton" type="submit" id="searchsubmit" value="Search">
  </div>
</form>

Text Content

 * 1-800-913-2022


 * Homepage
 * About
   * Company Profile
   * Careers
   * Contact Us
 * Technology
   * Immunofluorescence
   * Microplate ELISA
   * Blot Techniques
   * Allergy
   * EUROArray
 * Products
   * Catalog
   * Autoimmune Diagnostics
     * Rheumatology
     * Vasculitis
     * Hepatology
     * Nephrology
     * Gastroenterology
     * Dermatology
     * Neurology
   * Infectious Serology
     * Infectious Disease
     * Coronavirus
   * Allergy Diagnostics
     * Allergy
   * Antigen Detection
     * Hormones and Proteins
   * Molecular Diagnostics
     * EUROArray
   * Automation
     * EUROLabWorkstation
     * EUROPattern Suite
     * EUROStar III Plus
     * EUROLineScan
     * EUROBlotMaster
     * EUROBlotOne
     * IF Sprinter
     * MERGITE
     * Sprinter XL
     * Analyzer I
 * FDA Cleared
   * ELISA
   * EUROLine/Westernblot
   * IFA
 * News & Events
   * Recent News
   * Events
   * Videos
 * Academy
   * Webinars
   * Blog
   * P.A.C.E.


NEW SARS-COV-2 VARIANTS OF CONCERN (VOC), VARIANTS OF INTEREST (VUI) OR UNDER
MONITORING (VUM). CLICK HERE TO LEARN MORE

BLOG
COVID
A World Leader in the Field of Medical Diagnostics EUROIMMUN US ABOUT US Learn
about our comprehensive SARS-CoV-2 portfolio for diagnosing COVID-19,
quantifying antibody levels, determining cellular immune response, and measuring
neutralizing antibodies COVID LEARN MORE CogniScience, bringing you fascinating
scientific data, news, and interviews from experts in the diagnostics field
EUROIMMUN US BLOG VISIT OUR BLOG The World’s Fastest Computer-aided
Immunofluorescence Microscope EPA Live FIND OUT MORE


PRODUCT PORTFOLIO




AUTOIMMUNE DIAGNOSTICS


INFECTIOUS SEROLOGY


ALLERGY DIAGNOSTICS


ANTIGEN DETECTION


MOLECULAR DIAGNOSTICS


AUTOMATION




ABOUT US



EUROIMMUN US, Inc., a subsidiary of EUROIMMUN, is a world leader in the field of
medical diagnostics. .EUROIMMUN established itself as an industry innovator with
its unique IFA BIOCHIP Mosaic technology and has successfully introduced new
technologies such as ELISA, Western & Immunoblot assays since its inception in
1987. The company’s global success is attributed to its strategic product
development in which designer antigens, as well as patented and licensed
technologies, play an important role. EUROIMMUN is consistently expanding its
product offerings with new assays to aid in the detection of antibodies
associated with autoimmune and infectious diseases.


Learn More



RECENT NEWS

 * July 27, 2017


AUTOIMMUNE ENCEPHALITIS – ANTI NMDAR AND BEYOND

Read More
 * June 21, 2017


EUROIMMUN US LYME WEBINAR

Read More
 * June 11, 2017


APHL ANNUAL MEETING

Read More
 * February 3, 2022


U.S. CENTERS FOR DISEASE CONTROL GUIDANCE INCLUDES EUROIMMUN ASSAY IN ITS
TWO-STEP TESTING ALGORITHM FOR DENGUE VIRUS

Read More
 * November 30, 2021


NEW SARS-COV-2 VARIANTS OF CONCERN (VOC), VARIANTS OF INTEREST (VUI) OR UNDER
MONITORING (VUM)

Read More
 * October 5, 2021


EUROIMMUN ANTI-SARS-COV-2 S1 CURVE ELISA RECEIVES FDA EMERGENCY USE
AUTHORIZATION

Read More
 * June 24, 2021


SARS-COV-2 VARIANTS OF CONCERN (VOC) ALPHA, BETA, GAMMA AND DELTA

Read More
 * March 20, 2021


MONITORING OF TNF-Α INHIBITORS IN CHRONIC AUTOIMMUNE DISEASES

Read More
 * March 10, 2021


ONSET OF AUTOIMMUNE DISEASES FOLLOWING COVID-19 INFECTION

Read More
 * March 1, 2021


EQUIVALENT PERFORMANCE BETWEEN EUROIMMUN ELISA- AND SIMOA-BASED PLATFORM FOR
DETECTING CEREBRAL AMYLOIDOSIS

Read More
 * June 18, 2020


COVID-19 RT-PCR TEST RECEIVES FDA EMERGENCY USE AUTHORIZATION

Read More
 * May 5, 2020


FDA PROVIDES EMERGENCY USE AUTHORIZATION TO PERKINELMER FOR SEROLOGICAL TEST TO
IDENTIFY COVID-19 ANTIBODIES

Read More
 * April 17, 2020


ABC NEWS: LARGEST ANTIBODY STUDY COULD ANSWER CRUCIAL CORONAVIRUS QUESTIONS

Read More
 * July 25, 2019


PERKINELMER AND EVERLYWELL ANNOUNCE COLLABORATION TO EXPAND U.S. AT-HOME HEALTH
TEST MARKET

Read More
 * April 3, 2019


PERKINELMER RECEIVES FDA CLEARANCE FOR EUROIMMUN ANTI-TISSUE TRANSGLUTAMINASE
ELISA

Read More
 * November 20, 2018


MEMBRANOUS NEPHROPATHY: ANTIBODY-BASED DIAGNOSIS, PROGNOSIS, AND DISEASE
MONITORING

Read More
 * June 20, 2018


PERKINELMER’S EUROIMMUN RECEIVES 510(K) CLEARANCE FOR CRITHIDIA LUCILIAE AND
CRITHIDIA LUCILIAE SENSITIVE DIAGNOSTIC TESTS

Read More
 * February 27, 2018


MEASLES AND MUMPS FORGOTTEN DISEASES OF RECURRING RELEVANCE

Read More
 * August 13, 2017


AMLI ANNUAL MEETING 2017

Read More
 * July 30, 2017


EUROIMMUN 69TH AACC ANNUAL SCIENTIFIC MEETING & CLINICAL LAB EXPO

Read More
 * July 27, 2017


AUTOIMMUNE ENCEPHALITIS – ANTI NMDAR AND BEYOND

Read More
 * June 21, 2017


EUROIMMUN US LYME WEBINAR

Read More
 * June 11, 2017


APHL ANNUAL MEETING

Read More
 * February 3, 2022


U.S. CENTERS FOR DISEASE CONTROL GUIDANCE INCLUDES EUROIMMUN ASSAY IN ITS
TWO-STEP TESTING ALGORITHM FOR DENGUE VIRUS

Read More
 * November 30, 2021


NEW SARS-COV-2 VARIANTS OF CONCERN (VOC), VARIANTS OF INTEREST (VUI) OR UNDER
MONITORING (VUM)

Read More
 * October 5, 2021


EUROIMMUN ANTI-SARS-COV-2 S1 CURVE ELISA RECEIVES FDA EMERGENCY USE
AUTHORIZATION

Read More


 * Home
 * About
 * Technology
 * Products
 * FDA Cleared
 * News and Events
 * Contact

EUROIMMUN US, Inc.

1 Bloomfield Ave,

Mountain Lakes, NJ 07046

Phone: 973-656-1000 / 800-913-2022

Fax: 973-656-1098



Connect with us

 * 
 * 
 * 
 * 
 * 

Web Design & Development time4design



© Copyright EUROIMMUN US, Inc. 2022. All rights reserved.



Notifications